NCT00899301 Collecting and Storing Tissue Samples From Women With or Without Breast Cancer
| NCT ID | NCT00899301 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Vanderbilt-Ingram Cancer Center |
| Condition | Breast Cancer |
| Study Type | OBSERVATIONAL |
| Enrollment | 4,000 participants |
| Start Date | 2004-01-22 |
| Primary Completion | 2027-03 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 4,000 participants in total. It began in 2004-01-22 with a primary completion date of 2027-03.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
RATIONALE: Collecting and storing samples of tissue, blood, and urine from patients with or without breast cancer to study in the laboratory may help the study of cancer. PURPOSE: This research study is collecting and storing tissue samples from women with or without breast cancer.
Eligibility Criteria
* Breast lesion which is suspected to be cancer or a known diagnosis of breast cancer (any stage, at any point in the disease trajectory) who agrees to donate tissue/body fluids. * Individuals of all races and ethnic groups are eligible for this trial. There is no restriction regarding age, race, or ethnicity. The trial is open to the accrual of men and women. * Must sign informed consent for study of tumor specimens as part of a research project. * Must give permission for their tumor specimens to be obtained from outside institutions for molecular analyses. * Must be willing to be followed for recurrence, relapse and death from disease. ELIGIBILITY CRITERIA FOR OPTIONAL PHYSICAL FUNCTION AND COGNITIVE ASSESSMENTS * Must be 60 years of age or older * Have completed initial round of cancer treatment * Have completed the optional online survey and opted-in for the physical function and cognitive assessments
Contact & Investigator
VICC Clinical Trials Information Program
📞 800-811-8480
A. Bapsi Chakravarthy, MD
PRINCIPAL INVESTIGATOR
Vanderbilt-Ingram Cancer Center
Frequently Asked Questions
Who can join the NCT00899301 clinical trial?
This trial is open to female participants only, aged 18 Years or older, studying Breast Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT00899301 currently recruiting?
Yes, NCT00899301 is actively recruiting participants. Visit ClinicalTrials.gov or contact Vanderbilt-Ingram Cancer Center to inquire about joining.
Where is the NCT00899301 trial being conducted?
This trial is being conducted at Nashville, United States.
Who is sponsoring the NCT00899301 clinical trial?
NCT00899301 is sponsored by Vanderbilt-Ingram Cancer Center. The principal investigator is A. Bapsi Chakravarthy, MD at Vanderbilt-Ingram Cancer Center. The trial plans to enroll 4,000 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.